Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$6,141,082
+$1,415,304 QoQ
Shares Held
5,120
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.43%
of 13F equity value
Holder Rank
#1,558
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Iowa State Bank holds $35,695,888 across 7 Drug Manufacturers - General names. LLY ranks #3 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
45,266 | $11,390,736 | |
| 2 | JNJ |
Johnson & Johnson
|
33,394 | $8,481,074 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
5,120 | $6,141,082 | |
| 4 | AMGN |
Amgen Inc
|
9,653 | $3,495,544 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
18,782 | $2,372,917 | |
| 6 | PFE |
Pfizer Inc
|
87,501 | $2,107,024 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
29,634 | $1,707,511 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,141,082 | 5,120 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $4,725,778 | 5,138 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $6,078,390 | 5,656 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $4,262,118 | 5,586 | Shares | Sole | 2025-10-03 | |
| 2025-06-30 | $4,355,234 | 5,587 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $4,585,452 | 5,552 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $4,425,104 | 5,732 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $4,971,895 | 5,612 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $4,664,517 | 5,152 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $3,846,234 | 4,944 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $2,706,497 | 4,643 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $606,956 | 1,130 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $529,947 | 1,130 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $388,064 | 1,130 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $396,570 | 1,084 | Shares | Sole | 2023-01-06 | |
| 2022-09-30 | $386,403 | 1,195 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $449,382 | 1,386 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $396,908 | 1,386 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $407,700 | 1,476 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $350,271 | 1,516 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $347,952 | 1,516 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $283,219 | 1,516 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $262,039 | 1,552 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $229,727 | 1,552 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $261,374 | 1,592 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $567,642 | 4,092 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||